US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist

8.550
+0.320+3.89%

Trading May 2 12:17 ET

263.99MMarket Cap-3120P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-41.58%-42.64M

-32.20%-12.37M

-50.38%-9.81M

-56.46%-9.11M

-34.91%-11.36M

-115.40%-30.12M

-157.90%-9.35M

-181.81%-6.52M

-5.82M

-8.42M

Net income from continuing operations

-93.76%-60.39M

-115.61%-19.25M

-57.27%-14.47M

-139.07%-13.91M

-76.68%-12.76M

-91.88%-31.17M

-105.60%-8.93M

-276.97%-9.2M

---5.82M

---7.22M

Depreciation and amortization

47.25%536K

19.20%149K

14.66%133K

65.38%129K

177.78%125K

883.78%364K

861.54%125K

1,188.89%116K

--78K

--45K

Other non cash items

6.43%778K

3.19%194K

7.61%198K

7.73%195K

7.30%191K

-36.10%731K

-6.93%188K

-26.98%184K

--181K

--178K

Change In working capital

631.20%8.14M

323.09%4.17M

-19.59%1.84M

616.13%2.56M

70.57%-430K

-567.07%-1.53M

-1,424.11%-1.87M

3,083.33%2.29M

---496K

---1.46M

-Change in prepaid assets

159.62%2.11M

106.73%168K

-105.10%-74K

188.28%1.42M

167.08%593K

-363.22%-3.54M

-295.40%-2.5M

1,849.40%1.45M

---1.61M

---884K

-Change in payables and accrued expense

153.63%6.78M

423.63%4.21M

107.52%2.1M

3.28%1.32M

-101.43%-848K

60.70%2.67M

-22.32%804K

262.37%1.01M

--1.28M

---421K

-Change in other current liabilities

-13.04%-754K

-21.02%-213K

-5.85%-181K

-12.80%-185K

-12.18%-175K

-16.61%-667K

33.08%-176K

-37.90%-171K

---164K

---156K

Cash from discontinued investing activities

Operating cash flow

-41.58%-42.64M

-32.20%-12.37M

-50.38%-9.81M

-56.46%-9.11M

-34.91%-11.36M

-115.40%-30.12M

-157.90%-9.35M

-181.81%-6.52M

---5.82M

---8.42M

Investing cash flow

Cash flow from continuing investing activities

135.80%50.72M

121.60%20.54M

103.36%1.52M

1,900.56%19.34M

2,347.47%9.33M

-59,427.73%-141.68M

-69,291.97%-95.07M

-45.12M

-1.07M

-415K

Net PPE purchase and sale

40.54%-1.29M

-358.57%-1.15M

--0

89.57%-112K

93.98%-25K

-810.08%-2.17M

-83.21%-251K

---426K

---1.07M

---415K

Net investment purchase and sale

137.28%52.01M

122.87%21.69M

103.39%1.52M

--19.45M

--9.35M

---139.51M

---94.82M

---44.69M

--0

Cash from discontinued investing activities

Investing cash flow

135.80%50.72M

121.60%20.54M

103.36%1.52M

1,900.56%19.34M

2,347.47%9.33M

-59,427.73%-141.68M

-69,291.97%-95.07M

---45.12M

---1.07M

---415K

Financing cash flow

Cash flow from continuing financing activities

-101.53%-1.55M

-101.97%-2.01M

155.71%78K

-9.37%101.71M

2.11%101.86M

-14,100.00%-140K

Net common stock issuance

--0

----

--104.46M

----

Proceeds from stock option exercised by employees

3,129.17%775K

--318K

225.00%78K

----

2,300.00%24K

--0

--24K

----

Net other financing activities

16.01%-2.33M

----

---2.77M

---2.6M

---164K

----

Cash from discontinued financing activities

Financing cash flow

-101.53%-1.55M

-101.97%-2.01M

155.71%78K

3,545.45%379K

--0

-9.37%101.71M

2.11%101.86M

-14,100.00%-140K

---11K

--0

Net cash flow

Beginning cash position

-70.09%29.91M

-6.77%30.27M

-54.32%38.48M

-69.42%27.88M

-70.09%29.91M

4,924.67%99.99M

711.29%32.47M

1,234.11%84.25M

--91.16M

--99.99M

Current changes in cash

109.31%6.52M

340.49%6.16M

84.14%-8.21M

253.50%10.61M

77.02%-2.03M

-171.51%-70.08M

-102.67%-2.56M

-2,138.69%-51.78M

---6.91M

---8.83M

End cash Position

21.81%36.43M

-6.77%30.27M

-54.32%38.48M

-69.42%27.88M

-70.09%29.91M

711.29%32.47M

--84.25M

--91.16M

Free cash flow

-36.07%-43.93M

-40.73%-13.52M

-41.15%-9.81M

-33.72%-9.22M

-28.86%-11.38M

-127.03%-32.28M

-155.18%-9.61M

-200.22%-6.95M

---6.9M

---8.83M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-41.58%-42.64M	-32.20%-12.37M	-50.38%-9.81M	-56.46%-9.11M	-34.91%-11.36M	-115.40%-30.12M	-157.90%-9.35M	-181.81%-6.52M	-5.82M	-8.42M
Net income from continuing operations	-93.76%-60.39M	-115.61%-19.25M	-57.27%-14.47M	-139.07%-13.91M	-76.68%-12.76M	-91.88%-31.17M	-105.60%-8.93M	-276.97%-9.2M	---5.82M	---7.22M
Depreciation and amortization	47.25%536K	19.20%149K	14.66%133K	65.38%129K	177.78%125K	883.78%364K	861.54%125K	1,188.89%116K	--78K	--45K
Other non cash items	6.43%778K	3.19%194K	7.61%198K	7.73%195K	7.30%191K	-36.10%731K	-6.93%188K	-26.98%184K	--181K	--178K
Change In working capital	631.20%8.14M	323.09%4.17M	-19.59%1.84M	616.13%2.56M	70.57%-430K	-567.07%-1.53M	-1,424.11%-1.87M	3,083.33%2.29M	---496K	---1.46M
-Change in prepaid assets	159.62%2.11M	106.73%168K	-105.10%-74K	188.28%1.42M	167.08%593K	-363.22%-3.54M	-295.40%-2.5M	1,849.40%1.45M	---1.61M	---884K
-Change in payables and accrued expense	153.63%6.78M	423.63%4.21M	107.52%2.1M	3.28%1.32M	-101.43%-848K	60.70%2.67M	-22.32%804K	262.37%1.01M	--1.28M	---421K
-Change in other current liabilities	-13.04%-754K	-21.02%-213K	-5.85%-181K	-12.80%-185K	-12.18%-175K	-16.61%-667K	33.08%-176K	-37.90%-171K	---164K	---156K
Cash from discontinued investing activities
Operating cash flow	-41.58%-42.64M	-32.20%-12.37M	-50.38%-9.81M	-56.46%-9.11M	-34.91%-11.36M	-115.40%-30.12M	-157.90%-9.35M	-181.81%-6.52M	---5.82M	---8.42M
Investing cash flow
Cash flow from continuing investing activities	135.80%50.72M	121.60%20.54M	103.36%1.52M	1,900.56%19.34M	2,347.47%9.33M	-59,427.73%-141.68M	-69,291.97%-95.07M	-45.12M	-1.07M	-415K
Net PPE purchase and sale	40.54%-1.29M	-358.57%-1.15M	--0	89.57%-112K	93.98%-25K	-810.08%-2.17M	-83.21%-251K	---426K	---1.07M	---415K
Net investment purchase and sale	137.28%52.01M	122.87%21.69M	103.39%1.52M	--19.45M	--9.35M	---139.51M	---94.82M	---44.69M	--0	--0
Cash from discontinued investing activities
Investing cash flow	135.80%50.72M	121.60%20.54M	103.36%1.52M	1,900.56%19.34M	2,347.47%9.33M	-59,427.73%-141.68M	-69,291.97%-95.07M	---45.12M	---1.07M	---415K
Financing cash flow
Cash flow from continuing financing activities	-101.53%-1.55M	-101.97%-2.01M	155.71%78K			-9.37%101.71M	2.11%101.86M	-14,100.00%-140K
Net common stock issuance	--0	----	----	----	----	--104.46M	----	----	----	----
Proceeds from stock option exercised by employees	3,129.17%775K	--318K	225.00%78K	----	----	2,300.00%24K	--0	--24K	----	----
Net other financing activities	16.01%-2.33M	----	----	----	----	---2.77M	---2.6M	---164K	----	----
Cash from discontinued financing activities
Financing cash flow	-101.53%-1.55M	-101.97%-2.01M	155.71%78K	3,545.45%379K	--0	-9.37%101.71M	2.11%101.86M	-14,100.00%-140K	---11K	--0
Net cash flow
Beginning cash position	-70.09%29.91M	-6.77%30.27M	-54.32%38.48M	-69.42%27.88M	-70.09%29.91M	4,924.67%99.99M	711.29%32.47M	1,234.11%84.25M	--91.16M	--99.99M
Current changes in cash	109.31%6.52M	340.49%6.16M	84.14%-8.21M	253.50%10.61M	77.02%-2.03M	-171.51%-70.08M	-102.67%-2.56M	-2,138.69%-51.78M	---6.91M	---8.83M
End cash Position	21.81%36.43M	21.81%36.43M	-6.77%30.27M	-54.32%38.48M	-69.42%27.88M	-70.09%29.91M	-70.09%29.91M	711.29%32.47M	--84.25M	--91.16M
Free cash flow	-36.07%-43.93M	-40.73%-13.52M	-41.15%-9.81M	-33.72%-9.22M	-28.86%-11.38M	-127.03%-32.28M	-155.18%-9.61M	-200.22%-6.95M	---6.9M	---8.83M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall